webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

ADC toxin 1

  CAS No.: 723340-57-6   Cat No.: BADC-01617 4.5  

ADC toxin 1 is an ADC cytotoxin with anti-cancer activities. ADC toxin 1 is against  HCT-116 and PSN1 cells growth with both IC50 values of 0.86 µM.

ADC toxin 1

Structure of 723340-57-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Cytotoxin
Molecular Formula
C73H97IN6O25S3
Molecular Weight
1681.68

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(1S,2S,5R,7R,10S,11S,14R,16R,19S,20S,23R,25R)-5,14-diethyl-2,11,20,23-tetramethyl-4,13,22,28,29,30-hexaoxatetracyclo[23.2.1.1,(1).1(1),(1)]triacontane-3,12,21-trione; (3S,4S,7R,9R,12S,13S,16R,18R,21S,22S,25R,27R)-4,7:13,16:22,25-Triepoxy-3,9,12,21-tetramethyl-18,27-diethyl-1,10,19-trioxacycloheptacosane-2,11,20-trione
IUPAC Name
(1S,2S,5R,7R,10S,11S,14R,16R,19S,20S,23R,25R)-5,14-diethyl-2,11,20,23-tetramethyl-4,13,22,28,29,30-hexaoxatetracyclo[23.2.1.17,10.116,19]triacontane-3,12,21-trione
Canonical SMILES
CCC1CC2CCC(O2)C(C(=O)OC(CC3CCC(O3)C(C(=O)OC(CC4CCC(O4)C(C(=O)O1)C)CC)C)C)C
InChI
InChI=1S/C32H52O9/c1-7-22-16-25-10-13-27(38-25)19(4)30(33)36-18(3)15-24-9-12-28(37-24)20(5)31(34)40-23(8-2)17-26-11-14-29(39-26)21(6)32(35)41-22/h18-29H,7-17H2,1-6H3/t18-,19+,20+,21+,22-,23-,24-,25-,26-,27+,28+,29+/m1/s1
InChIKey
MXZXIBZNZUOHER-VHWZNAHMSA-N

ADC Toxin 1 is a chemically defined cytotoxic agent designed as an ADC payload for use in antibody-drug conjugates. Its mechanism involves the disruption of microtubule dynamics, leading to mitotic arrest and apoptosis in proliferating tumor cells. The molecular structure of ADC Toxin 1 enables efficient conjugation to monoclonal antibodies through cleavable or non-cleavable linkers, facilitating precise intracellular delivery of cytotoxic activity.

Within antibody-drug conjugates, ADC Toxin 1 is attached to antibodies via linker chemistries that provide systemic stability and controlled release within target cells. Upon antibody-mediated internalization, enzymatic or chemical cleavage liberates the payload, enabling direct interaction with intracellular targets. This mechanism ensures site-specific cytotoxicity and reduces off-target effects, supporting controlled therapeutic outcomes in tumor-targeted applications.

Applications of ADC Toxin 1 include incorporation into ADCs targeting a range of hematologic malignancies and solid tumors. Its compatibility with various linker systems allows optimization of intracellular release kinetics, antibody conjugation stability, and pharmacokinetic profiles. ADC Toxin 1 exhibits defined cytotoxic potency in target-expressing cell lines and supports the development of ADCs with precise antitumor mechanisms and predictable therapeutic performance.

What is ADC toxin 1?

ADC toxin 1 is a general term for a potent cytotoxic payload used in experimental antibody-drug conjugates. It is designed to disrupt key cellular processes, induce apoptosis, and serve as a model payload in preclinical ADC research.

1/7/2017

Could you explain how ADC toxin 1 functions in ADCs?

ADC toxin 1 is conjugated to targeting antibodies, allowing selective internalization into cancer cells. Once inside, it interferes with critical cellular pathways, leading to apoptosis and providing a controlled model for ADC development.

22/3/2019

We are interested in the research applications of ADC toxin 1. Could you advise?

ADC toxin 1 is used to evaluate antibody conjugation strategies, payload potency, and intracellular delivery mechanisms. It supports optimization of preclinical ADC designs for cancer therapy research.

22/8/2022

What are the chemical features of ADC toxin 1?

ADC toxin 1 is a small molecule with functional groups suitable for stable conjugation to antibodies. Its chemical properties allow efficient intracellular release and potent cytotoxic activity in target cells.

12/8/2019

Dear team, what laboratory precautions are needed when handling ADC toxin 1?

Handling ADC toxin 1 requires strict safety protocols, including use of PPE, containment systems, and controlled waste disposal, to prevent exposure and ensure safe ADC research practices.

25/5/2016

— Dr. James Parker, Lead Scientist (USA)

ADC toxin 1 from BOC Sciences arrived with excellent purity, supporting our ADC projects.

22/8/2022

— Dr. Emily Carter, Pharmacology Researcher (USA)

The ADC toxin 1 offered by BOC Sciences showed excellent solubility and consistent biological activity in our tests. It’s a reliable option for ADC development.

25/5/2016

— Mr. Thomas Müller, CMC Specialist (Germany)

We chose ADC toxin 1 for pilot conjugation work and were impressed with the documentation package, which met all compliance standards.

12/8/2019

— Ms. Sophie Dubois, Laboratory Head (France)

BOC Sciences provided ADC toxin 1 with high purity and timely delivery. This reliability supported our preclinical studies greatly.

1/7/2017

— Dr. Michael Brown, Senior Biologist (UK)

Our team has tested ADC toxin 1 in multiple conjugation systems and consistently achieved robust results. We value their dependable supply chain.

— Mr. Luca Romano, Biotech Project Manager (Italy)

The performance of ADC toxin 1 was impressive, and the support team answered all of our technical queries quickly and professionally.

22/3/2019

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Payload Development Biological Payload Chemical Payload Protein Toxin Nanocarrier Microtubule Inhibitors DNA Damaging Agents RNA Polymerase Inhibitors Protein Degraders

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Maytansine and Its Analogues Cytotoxic Agents Used in Antibody–Drug Conjugates Exatecan Mesylate in ADCs: A New Topo I Inhibitor What is Calicheamicin? What is Monomethyl Auristatin E (MMAE)? What is Monomethyl Auristatin F (MMAF)? What is Pyrrolobenzodiazepine (PBD)? Antiviral Potential of Thapsigargin in COVID-19 Research ADC Payloads Explained: Current Types and Cutting-Edge Research Progress Tubulin Inhibitors - Highly Potential ADC Payloads

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Biotin-PEG4-SS-Alkyne | 4-formylphenyl 3-iodo-4-methoxybenzoate | DM4-SMe | PSMA-ALB-56 | Fmoc-NH-ethyl-SS-propionic acid | MMAD | Amino-PEG4-bis-PEG3-N3 | Bis-PEG7-NHS ester | N-(2-(3-Ethylphenoxy)ethyl)-4-Formylbenzamide | D8-MMAF | ADC toxin 1
Send Inquiry
Verification code
Inquiry Basket